Stock Market News

US FDA expands use of ARS Pharma's allergic reaction nasal spray in 15-30 kg patients

Mar 5, 2025 - 23:08
 0
US FDA expands use of ARS Pharma's allergic reaction nasal spray in 15-30 kg patients
Read More

Tags:

Previous Article

Panama leader accuses Trump of lying to Congress over canal

Next Article

Decoding Ackman's $900 Million Proposal For Howard Hughes

Related Posts

Fed's Williams discusses economy's journey and future

Fed's Williams discusses economy's journey and future

Feb 11, 2025  0

Warner Bros jumps on streaming profits guide, encouragi...

Feb 27, 2025  0

Sanofi's Rilzabrutinib gets orphan designation by FDA for AIHA treatment

Sanofi's Rilzabrutinib gets orphan designation by FDA f...

Feb 20, 2025  0